Outlook Therapeutics: Navigating Risks in Supply Chain Dependence
Outlook Therapeutics, known by its ticker OTLK, has recently highlighted a new set of challenges. The company relies heavily on external manufacturers, primarily FUJIFILM Diosynth Biotechnologies, for making and supplying their drug candidates like ONS-5010/LYTENAVA. This outsourcing isn't without i